HAGENS BERMAN Alerts Cassava Sciences, Inc. (SAVA) Investors to Securities Fraud Class Action, Encourages Investors with Losses to Contact Firm’s Attorneys Now
The petition raises serious concerns about the quality and integrity of the laboratory-based studies surrounding this drug candidate.
- The petition raises serious concerns about the quality and integrity of the laboratory-based studies surrounding this drug candidate.
- Were focused on investors losses and proving Cassava manipulated clinical data for simufilam, said Reed Kathrein, the Hagens Berman partner leading the investigation.
- If you invested in Cassava and have significant losses, or have knowledge that may assist the firms investigation, click here to discuss your legal rights with Hagens Berman .
- Hagens Berman is a national law firm with eight offices in eight cities around the country and over eighty attorneys.